DE3560262D1 - Hexapeptide, process for its preparation and pharmaceutical compositions thereof - Google Patents

Hexapeptide, process for its preparation and pharmaceutical compositions thereof

Info

Publication number
DE3560262D1
DE3560262D1 DE8585400168T DE3560262T DE3560262D1 DE 3560262 D1 DE3560262 D1 DE 3560262D1 DE 8585400168 T DE8585400168 T DE 8585400168T DE 3560262 T DE3560262 T DE 3560262T DE 3560262 D1 DE3560262 D1 DE 3560262D1
Authority
DE
Germany
Prior art keywords
hexapeptide
preparation
pharmaceutical compositions
pro
ile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8585400168T
Other languages
English (en)
Inventor
Pierre Jolles
Daniele Migliore-Samour
Fabienne Parker
Monika Casaretto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of DE3560262D1 publication Critical patent/DE3560262D1/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732Casein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE8585400168T 1984-02-07 1985-02-01 Hexapeptide, process for its preparation and pharmaceutical compositions thereof Expired DE3560262D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8401816A FR2559157B1 (fr) 1984-02-07 1984-02-07 Nouvel hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent

Publications (1)

Publication Number Publication Date
DE3560262D1 true DE3560262D1 (en) 1987-07-23

Family

ID=9300812

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585400168T Expired DE3560262D1 (en) 1984-02-07 1985-02-01 Hexapeptide, process for its preparation and pharmaceutical compositions thereof

Country Status (7)

Country Link
US (1) US4637997A (de)
EP (1) EP0155199B1 (de)
JP (1) JPS60188399A (de)
AT (1) ATE27822T1 (de)
CA (1) CA1250810A (de)
DE (1) DE3560262D1 (de)
FR (1) FR2559157B1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0680014B2 (ja) * 1985-12-10 1994-10-12 雪印乳業株式会社 低分子ペプチドを有効成分とする免疫賦活剤及びその調製法
DE3736589A1 (de) * 1987-10-29 1989-05-11 Behringwerke Ag Glutaminhaltige peptide, verfahren zu deren herstellung und verwendung
ES2146651T3 (es) * 1994-05-12 2000-08-16 Balazs Sarkadi Compuestos para anular resistencias a medicamentos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558770A (en) * 1967-09-01 1971-01-26 Kraftco Corp Wound treating composition employing an enzyme modified casein
FR2491334A1 (fr) * 1980-10-03 1982-04-09 Inst Nat Sante Rech Med Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant
FR2513881A2 (fr) * 1980-10-03 1983-04-08 Inst Nat Sante Rech Med Nouvelles substances biologiquement actives, leur obtention a partir de caseine humaine et compositions les contenant

Also Published As

Publication number Publication date
FR2559157B1 (fr) 1986-08-01
CA1250810A (fr) 1989-03-07
ATE27822T1 (de) 1987-07-15
FR2559157A1 (fr) 1985-08-09
EP0155199A1 (de) 1985-09-18
US4637997A (en) 1987-01-20
EP0155199B1 (de) 1987-06-16
JPS60188399A (ja) 1985-09-25

Similar Documents

Publication Publication Date Title
BG103335A (en) Application of fumaric acid derivatives
EP1440980A3 (de) Peptidanaloge des menschlichen, basischen Myelinproteins
IL112585A (en) N-terminally chemically modified G-CSF and analogs process for their preparation and pharmaceutical compositions containing them
WO2000053758A3 (en) Compositions and methods for the treatment of immune related diseases
HU895334D0 (en) Process for the preparation of nasal pharmaceutical compositions
IL86782A (en) Amino acid derivatives, processes for the preparation thereof and pharmaceutical compositions comprising the same
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
PT86018A (en) Process for the preparation of alpha-amino-alpha-(alkylphenyl)-alkyl-ethanoic acids and their by-products and pharmaceutical compositions therewith
EP0414275A3 (en) Process for the preparation of cyclic aminoacid derivitives as well as the intermediate products
IL75637A0 (en) Thymopentin analogs and pharmaceutical compositions containing them
GR82243B (de)
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
WO2000073452A3 (en) Compositions and methods for the treatment of immune related diseases
WO1996028470A3 (en) Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
DE3462039D1 (en) Peptide derivatives, their preparation and use as elastase inhibitors
EP0339695A3 (de) Verfahren zur Herstellung eines antigenen bzw. immunogenen Konjugats sowie die Verwendung solcher Konjugate
PT84064A (en) Process for the preparation of novel amino acid derivatives and of pharmaceutical compositions containing the same
DE3380629D1 (en) Region-specific determinants for vitamin k dependent bone protein
IL69475A (en) Polypeptide having an action on the immunological system,processes for its isolation and purification,its protease cleavage products and pharmaceutical compositions containing them
FR2651435B1 (de)
DE3568048D1 (en) Process for the synthesis of peptides
HU905877D0 (en) Process for producing recombinant aprothinine derivatives and pharmaceutical preparatives containing these compounds
DE3560262D1 (en) Hexapeptide, process for its preparation and pharmaceutical compositions thereof
HUT52117A (en) Process for producing amblyommin and process for producing pharmaceutical compositions comprising such compound as active ingredient
IE892094L (en) New strontium salt, process for the preparation thereof and¹pharmaceutical compositions containing it

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee